Patents by Inventor Davar Khossravi

Davar Khossravi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystalline form of a substituted pyrrolidine compound
    Patent number: 7524880
    Abstract: The invention provides a crystalline naphthalene-1,5-disulfonic acid salt of 2-[(S)-1-(8-methylaminooctyl)pyrrolidin-3-yl]-2,2-diphenylacetamide or a solvate thereof. This invention also provides pharmaceutical compositions comprising the salt or prepared using the salt; processes and intermediates for preparing the salt; and methods of using the salt to treat a pulmonary disorder.
    Type: Grant
    Filed: June 9, 2005
    Date of Patent: April 28, 2009
    Assignee: Theravance, Inc.
    Inventors: Li Li, Robert Chao, Adam Hughes, Yu-Hua Ji, Davar Khossravi, Weijiang Zhang
  • Crystalline form of a substituted pyrrolidine compound
    Publication number: 20050277688
    Abstract: The invention provides a crystalline naphthalene-1,5-disulfonic acid salt of 2-[(S)-1-(8-methylaminooctyl)pyrrolidin-3-yl]-2,2-diphenylacetamide or a solvate thereof. This invention also provides pharmaceutical compositions comprising the salt or prepared using the salt; processes and intermediates for preparing the salt; and methods of using the salt to treat a pulmonary disorder.
    Type: Application
    Filed: June 9, 2005
    Publication date: December 15, 2005
    Inventors: Li Li, Robert Chao, Adam Hughes, Yu-Hua Ji, Davar Khossravi, Weijiang Zhang
  • Crystalline beta2 adrenergic receptor agonist
    Publication number: 20050075271
    Abstract: The invention provides a crystalline salt form of a novel ?2 adrenergic receptor agonist. The invention also provides pharmaceutical compositions comprising the crystalline form, formulations containing the pharmaceutical compositions, methods of using the crystalline salt form to treat diseases associated with ?2 adrenergic receptor activity, and processes useful for preparing such a crystalline compound.
    Type: Application
    Filed: July 25, 2003
    Publication date: April 7, 2005
    Inventors: Martin Linsell, John Jacobsen, Davar Khossravi, Mehdi Paborji, Weijiang Zhang